Organogenesis Holdings Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
ORGO$0.94+3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net revenue | $115,177 | $108,531 | $355,387 | $333,489 |
| Cost of goods sold | 26,796 | 25,789 | 84,690 | 78,712 |
| Gross profit | 88,381 | 82,742 | 270,697 | 254,777 |
| Operating expenses: | ||||
| Selling, general and administrative | 71,795 | 64,222 | 220,657 | 208,373 |
| Research and development | 10,344 | 10,470 | 38,741 | 32,610 |
| Impairment of property and construction | — | — | 18,842 | — |
| Write down of capitalized internal-use software costs | — | — | 3,959 | — |
| Total operating expenses | 82,139 | 74,692 | 282,199 | 240,983 |
| Income (loss) from operations | 6,242 | 8,050 | (11,502) | 13,794 |
| Other expense, net: | ||||
| Interest expense, net | (471) | (444) | (1,605) | (1,688) |
| Other income, net | 52 | 31 | 47 | 82 |
| Total other expense, net | (419) | (413) | (1,558) | (1,606) |
| Net income (loss) before income taxes | 5,823 | 7,637 | (13,060) | 12,188 |
| Income tax benefit (expense) | 6,508 | (4,470) | 6,248 | (6,675) |
| Net income (loss) and comprehensive income (loss) | $12,331 | $3,167 | $(6,812) | $5,513 |
| Net income (loss) per share: | ||||
| Basic | $0.09 | $0.02 | $(0.05) | $0.04 |
| Diluted | $0.09 | $0.02 | $(0.05) | $0.04 |
| Weighted-average common shares outstanding | ||||
| Basic | 132,575,301 | 131,312,483 | 132,342,203 | 131,230,882 |
| Diluted | 133,926,755 | 133,417,721 | 132,342,203 | 132,790,296 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.